Your browser is no longer supported. Please, upgrade your browser.
SYNH Syneos Health, Inc. weekly Stock Chart
Syneos Health, Inc.
Index- P/E30.45 EPS (ttm)1.78 Insider Own0.50% Shs Outstand104.20M Perf Week-9.12%
Market Cap5.69B Forward P/E13.94 EPS next Y3.89 Insider Trans-8.86% Shs Float61.30M Perf Month-9.05%
Income187.50M PEG3.24 EPS next Q0.90 Inst Own- Short Float9.27% Perf Quarter-1.99%
Sales4.57B P/S1.25 EPS this Y467.60% Inst Trans-0.74% Short Ratio7.77 Perf Half Y51.02%
Book/sh28.79 P/B1.88 EPS next Y20.08% ROA2.50% Target Price73.38 Perf Year-1.63%
Cash/sh3.27 P/C16.58 EPS next 5Y9.41% ROE6.30% 52W Range30.02 - 74.25 Perf YTD-8.87%
Dividend- P/FCF17.55 EPS past 5Y34.80% ROI4.90% 52W High-27.00% Beta1.69
Dividend %- Quick Ratio1.10 Sales past 5Y31.70% Gross Margin21.80% 52W Low80.55% ATR2.16
Employees24000 Current Ratio1.10 Sales Q/Q-13.10% Oper. Margin5.50% RSI (14)32.47 Volatility3.51% 3.29%
OptionableYes Debt/Eq0.93 EPS Q/Q-65.50% Profit Margin4.10% Rel Volume1.86 Prev Close54.74
ShortableYes LT Debt/Eq0.89 EarningsAug 06 BMO Payout0.00% Avg Volume730.81K Price54.20
Recom2.10 SMA20-9.64% SMA50-11.05% SMA200-5.60% Volume1,360,806 Change-0.99%
Mar-30-20Downgrade Goldman Buy → Neutral $79 → $45
Jan-07-20Initiated Citigroup Buy $75
Oct-19-18Upgrade William Blair Mkt Perform → Outperform
Oct-09-18Initiated UBS Buy
Oct-04-18Initiated Evercore ISI Outperform $58
Sep-16-20 06:20PM  
Sep-15-20 04:51PM  
Sep-10-20 02:42PM  
Sep-09-20 10:55AM  
Sep-05-20 11:32AM  
Sep-02-20 07:30AM  
Sep-01-20 08:12AM  
Aug-11-20 09:50AM  
Aug-06-20 09:45AM  
Jul-30-20 12:33PM  
Jul-20-20 11:02AM  
Jul-13-20 08:30AM  
Jul-11-20 05:42PM  
Jul-10-20 10:00AM  
Jul-09-20 10:00AM  
Jul-07-20 08:00AM  
Jul-01-20 03:37PM  
Jun-22-20 08:42AM  
Jun-19-20 09:38AM  
Jun-17-20 01:52PM  
Jun-16-20 08:43AM  
May-30-20 11:31AM  
May-28-20 08:30AM  
May-22-20 08:39AM  
May-13-20 12:15PM  
May-04-20 10:26AM  
Apr-30-20 06:00PM  
Apr-23-20 12:32PM  
Apr-07-20 06:54AM  
Apr-03-20 04:17PM  
Apr-02-20 02:54PM  
Apr-01-20 02:31PM  
Mar-30-20 12:09PM  
Mar-27-20 05:13PM  
Mar-25-20 07:09AM  
Mar-21-20 11:30AM  
Mar-17-20 09:27AM  
Mar-05-20 04:05PM  
Feb-28-20 08:41AM  
Feb-25-20 01:59PM  
Feb-24-20 02:59PM  
Feb-21-20 07:46AM  
Feb-20-20 02:46PM  
Feb-19-20 06:56AM  
Feb-13-20 12:31PM  
Jan-22-20 09:00AM  
Jan-20-20 12:59PM  
Jan-09-20 07:00AM  
Jan-08-20 08:01AM  
Jan-03-20 06:00PM  
Dec-30-19 09:31AM  
Dec-11-19 03:56PM  
Dec-09-19 09:15AM  
Dec-02-19 09:30AM  
Nov-21-19 09:02AM  
Nov-20-19 09:10AM  
Nov-13-19 03:39PM  
Nov-12-19 04:30PM  
Nov-08-19 08:45AM  
Nov-05-19 09:30AM  
Nov-03-19 06:00AM  
Nov-01-19 10:26AM  
Oct-31-19 07:35AM  
Oct-25-19 11:23AM  
Oct-24-19 10:32AM  
Oct-23-19 09:49AM  
Oct-17-19 09:30AM  
Oct-16-19 11:17AM  
Oct-15-19 12:13PM  
Oct-14-19 06:00PM  
Oct-10-19 05:56PM  
Oct-09-19 07:56AM  
Syneos Health, Inc. operates as an integrated biopharmaceutical solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers various clinical development services spanning Phase I to Phase IV, including full-service global studies, as well as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with drug development process. The Commercial Solutions segment provides commercialization services, including medication adherence, communications solutions, and consulting services. Its customers include small, mid-sized, and large companies in the pharmaceutical, biotechnology, and medical device industries. Syneos Health, Inc. has a strategic agreement with Daiichi Sankyo, Inc. for the development of Daiichi Sankyo'S Adc oncology pipeline. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Macdonald AlistairChief Executive OfficerAug 03Sale65.0710,289669,464246,687Aug 04 05:06 PM
Macdonald AlistairChief Executive OfficerJul 15Option Exercise16.0637,868608,160280,088Jul 17 05:03 PM
Macdonald AlistairChief Executive OfficerJul 15Sale60.1437,8682,277,495261,154Jul 17 05:03 PM
Macdonald AlistairChief Executive OfficerJul 14Option Exercise10.575,17354,679266,327Jul 15 05:03 PM
Macdonald AlistairChief Executive OfficerJul 14Sale58.685,173303,553261,154Jul 15 05:03 PM
Macdonald AlistairChief Executive OfficerJul 13Option Exercise10.573,65538,633264,809Jul 15 05:03 PM
Macdonald AlistairChief Executive OfficerJul 13Sale58.213,655212,747261,154Jul 15 05:03 PM
Dineen John M.DirectorJul 06Buy59.118,691513,72517,426Jul 08 05:04 PM
KEEFE MICHELLEPres., Commercial SolutionsJul 06Sale59.111,50088,66550,443Jul 08 05:06 PM
KEEFE MICHELLEPres., Commercial SolutionsMay 20Sale60.002,500150,00051,943May 21 05:01 PM
Parks RobertEVP, Chief Accounting OfficerApr 20Sale49.653,588178,14412,450Apr 21 07:04 PM
Meggs Jason M.Chief Financial OfficerMar 20Buy36.743,555130,61363,829Mar 23 05:04 PM
COLVIN PAULPres., Clinical SolutionsMar 19Buy36.651,30047,64526,855Mar 23 05:06 PM
Meggs Jason M.Chief Financial OfficerMar 05Option Exercise0.005,094068,923Apr 15 06:39 PM
Macdonald AlistairChief Executive OfficerMar 05Option Exercise0.0031,2580248,937Apr 15 06:55 PM